Labi Health
To help companies turn weak signals into business opportunities, Simplex has developed an innovative tool: Indexa Surface. "If the company is attentive, it picks up on these subtle signals and turns them into an offer," says João Lee, CEO and Founder of Simplex. The Indexa Surface platform maps weak signals and enables the creation of strategic content, enhancing the connection between companies and their customers.
"In practice, the customer journey starts from the moment they access the website," explains Lee. The challenge is to identify what the customer is really looking for and capture the opportunity, even if the signs of buying intent are still not very obvious.
Indexa Surface is an advanced SEO solution that allows you to create optimized content on a large scale in anticipation of user searches. Using artificial intelligence, the tool generates a vast network of pages based on weak signals, significantly increasing the "surface" of contact between the consumer and the company.
Simplex's technology has already generated impressive results for clients such as clinical examination start-up Labi Saúde, which inspired the development of Indexa Surface. After a year of SEO optimizations and site strengthening, Labi's e-commerce traffic grew by 205%, while clicks on the blog increased by 1,135%.
On the data analysis and performance front, Simplex mapped the behavior of users from paid media who completed their purchases in physical units. This allowed the offline conversion rate to reach almost 40% in July 2023. In addition, Simplex took advantage of data from Labi's WhatsApp channel, reducing the Customer Acquisition Cost (CAC) by more than 200%.
With the support of Simplex's SEO, data analysis and performance solutions, Labi Saúde was able to turn weak signals into concrete business.
"I then had a 90% drop in my cost of acquisition when I began to understand that a lot of pages and a lot of what I generate in digital goes to the physical world and it goes through WhatsApp. It goes to a portal that I don't "track", but I started to have this visibility of the data, which is very important and gives us the confidence to invest."
Carolina D'Alençon | VP Marketing & Product | Labi Saúde